Profile
Salim Yazji is the founder of Elpida Therapeutics, Ajuta Therapeutics, Inc., and Versatope Therapeutics, Inc. He is currently the Director at Versatope Therapeutics, Inc. Dr. Yazji's former positions include Vice President-Global Therapeutics at Baxalta, Inc., Chief Medical Officer & Executive Vice President at Calimmune, Inc., and Chief Medical Officer at PMV Pharmaceuticals, Inc. He also served as the Chief Medical Officer at Oncternal Therapeutics, Inc. from 2021 to 2024.
Dr. Yazji obtained a doctorate degree from Pavlov First Saint Petersburg State Medical University.
Salim Yazji active positions
| Companies | Position | Start |
|---|---|---|
Versatope Therapeutics, Inc.
Versatope Therapeutics, Inc. BiotechnologyHealth Technology Operates as immuno-therapeutic company | Director/Board Member | 01/04/2019 |
Elpida Therapeutics | Founder | - |
Former positions of Salim Yazji
| Companies | Position | End |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2024 |
| BAXALTA INC | Corporate Officer/Principal | - |
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Chief Tech/Sci/R&D Officer | - |
| PMV PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Ajuta Therapeutics, Inc. | Chief Executive Officer | - |
Training of Salim Yazji
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Pavlov First Saint Petersburg State Medical University
Pavlov First Saint Petersburg State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Versatope Therapeutics, Inc.
Versatope Therapeutics, Inc. BiotechnologyHealth Technology Operates as immuno-therapeutic company | Health Technology |
Ajuta Therapeutics, Inc. | |
Elpida Therapeutics |
- Stock Market
- Insiders
- Salim Yazji
















